Загрузка...
Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir
Daclatasvir (DCV) and asunaprevir (ASV) are direct-acting antivirals (DAAs) used in the treatment of chronic hepatitis C virus (HCV) infection. Combined therapy with DCV and ASV shows high efficacy and safety even in patients with cirrhosis. We encountered a patient exhibiting severe hyperbilirubine...
Сохранить в:
| Опубликовано в: : | Case Rep Gastroenterol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965544/ https://ncbi.nlm.nih.gov/pubmed/27504082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000447486 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|